Journal name: World Journal of Pharmaceutical Research
Original article title: The role of the pharmacist in oncological patient safety
The WJPR includes peer-reviewed publications such as scientific research papers, reports, review articles, company news, thesis reports and case studies in areas of Biology, Pharmaceutical industries and Chemical technology while incorporating ancient fields of knowledge such combining Ayurveda with scientific data.
This page presents a generated summary with additional references; See source (below) for actual content.
Subtitle: literature review
Original source:
This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.
Silvânio Custódio Araújo and Ana Laura Remédio Zeni Beretta
World Journal of Pharmaceutical Research:
(An ISO 9001:2015 Certified International Journal)
Full text available for: The role of the pharmacist in oncological patient safety
Source type: An International Peer Reviewed Journal for Pharmaceutical and Medical and Scientific Research
Doi: 10.20959/wjpr20218-20937
Download the PDF file of the original publication
Summary of article contents:
Introduction
Cancer, or neoplasia, is a significant public health concern, particularly as it stands as the second leading cause of death in many regions, including the Western world. The rise in cancer incidence poses serious challenges to both physical and emotional health, with estimates indicating that there were around 18 million new cancer cases worldwide in 2018. In Brazil, projections for 2020-2022 suggested approximately 625,000 new cases annually. Antineoplastic chemotherapy is a primary treatment method, but the use of these high-risk drugs necessitates careful management to avoid medication errors and ensure patient safety. The pharmacist plays a crucial role in oncological care, overseeing pharmacotherapy and contributing to patient safety through comprehensive management of chemotherapy processes.
The Importance of the Oncologist Pharmacist
The role of the oncology pharmacist is critical in ensuring the safety and effectiveness of cancer treatment. Various studies emphasize that the presence of pharmacists in chemotherapy processes increases safety, enhances communication among the healthcare team, and optimizes therapeutic outcomes. For example, interventions by pharmacists in outpatient settings, such as double-checking patient information and assessing drug interactions, have been shown to improve care quality and patient safety significantly. This collaborative approach not only augments patient care but also fosters better adherence to treatment protocols.
Risk Management in Oncology
Managing risks in oncology is paramount, as failures in treatment administration can significantly jeopardize patient safety. One effective strategy involves the implementation of computerized order entry systems designed to minimize errors associated with chemotherapy regimens. Additionally, the creation of specialized roles for Certified Oncology Pharmacists, such as Limited Oncology Practice Providers, has shown to streamline the chemotherapy modification process and enhance the safety of treatment protocols. By facilitating drug monitoring and ensuring adherence to guidelines, these pharmacists play a vital role in maintaining a culture of safety within oncology departments.
Drug Interactions and Patient Care
The prevalence of drug interactions presents another significant concern in oncology, potentially affecting treatment outcomes and patient safety. Studies have indicated that pharmacists' involvement in monitoring medication regimens contributes to improved patient management and satisfaction. By educating patients on drug interactions and adverse effects, pharmacists help mitigate risks associated with cancer treatment. For instance, research demonstrating the efficacy of pharmacist-led interventions has shown that patients receiving such support reported fewer adverse drug reactions and improved overall satisfaction with their care.
Conclusion
The role of the oncology pharmacist is essential in enhancing patient safety and improving treatment processes within cancer care. Through risk management strategies, proactive monitoring of drug interactions, and collaboration with multidisciplinary teams, pharmacists significantly contribute to optimal treatment outcomes. As cancer treatment modalities continue to evolve, further research is warranted to fully understand and expand the pharmacists’ roles, ensuring that they remain integral to the management and care of oncological patients. The ongoing development of oncology pharmacy practices will be crucial in addressing the complexities of cancer treatment, ultimately enhancing patient safety and quality of care.
FAQ section (important questions/answers):
What is the role of pharmacists in cancer patient safety?
Pharmacists are essential in ensuring the safety and effectiveness of cancer treatments. They identify, resolve, and prevent drug-related problems while providing specialized care tailored to the patient's needs in a multidisciplinary team.
How prevalent are new cancer cases globally?
Recent studies indicate that there were 18 million new cancer cases worldwide, highlighting the seriousness of neoplastic diseases and the need for timely diagnosis and treatment to improve cure rates.
What are the risks associated with chemotherapy medications?
Chemotherapy drugs are classified as 'high-risk' due to their potential for causing harm when errors occur. This emphasizes the critical role pharmacists play in managing these medications safely.
What strategies improve patient safety in oncology care?
Strategies include computerized order entry systems, pharmacists' involvement in treatment decisions, and medication reconciliation programs, all aimed at minimizing errors and optimizing patient care.
How does pharmacist intervention affect cancer treatment outcomes?
Pharmacist involvement in cancer treatment leads to improved patient safety, adherence, and satisfaction, along with better management of adverse drug reactions, ultimately enhancing treatment outcomes.
What changes have occurred in pharmacy practice during the COVID-19 pandemic?
During the pandemic, pharmacists adapted by expanding their roles and exploring digital services, while ensuring patient safety and drug integrity in delivering cancer therapies under challenging circumstances.
Glossary definitions and references:
Scientific and Ayurvedic Glossary list for “The role of the pharmacist in oncological patient safety”. This list explains important keywords that occur in this article and links it to the glossary for a better understanding of that concept in the context of Ayurveda and other topics.
1) Cancer:
Cancer is a significant global health concern, representing the second leading cause of death in many regions. It encompasses various diseases characterized by uncontrolled cell growth. Effective management and treatment require a multidisciplinary approach, often involving oncology pharmacists to ensure patient safety through careful medication management and therapy selection.
2) Drug:
In the context of oncology, 'drugs' often refers to both traditional chemotherapeutic agents and novel therapies, including targeted and immunotherapies. Effective management and safe administration of these drugs require careful planning and monitoring to minimize errors and ensure optimal therapeutic outcomes for cancer patients.
3) Study (Studying):
A study in the medical context refers to a systematic investigation aimed at discovering and analyzing health-related outcomes or interventions. In oncology, studies are critical for identifying effective practices and treatments, as well as outlining the pharmacist's role in enhancing patient safety and ensuring proper medication management.
4) Chemotherapy:
Chemotherapy is a common treatment for cancer that uses potent drugs to target and kill rapidly dividing cancer cells. Although effective, it carries significant risks and potential side effects. The involvement of pharmacists in chemotherapy is essential to mitigate these risks and provide safe and effective patient care throughout the treatment process.
5) Pain:
Pain management is a crucial aspect of cancer treatment, as many patients experience significant pain due to their condition or the effects of treatments. Pharmacists play a key role in assessing and managing pain through appropriate medication selection, dosing, and monitoring to ensure patient comfort and adherence to therapy.
6) Education:
Education in the healthcare context involves providing patients and professionals with necessary knowledge about disease management, medication use, and safety procedures. For oncology pharmacists, educating patients on drug administration, potential side effects, and adherence is vital to improving patient outcomes and ensuring safe pharmacotherapy practices.
7) Disease:
Disease encompasses any abnormal condition affecting the body. In oncology, the focus on cancer as a specific disease underlines the complexity and variability in treatment approaches. Understanding the nuances of cancer is essential for pharmacists to deliver effective pharmaceutical care tailored to the patient's unique clinical status.
8) Quality:
Quality in healthcare often relates to the standard of care provided and the safety of medication formulations and administration. In oncology, achieving high-quality patient care is imperative, requiring pharmacists to engage in activities that monitor and improve treatment regimens, therefore enhancing outcomes for cancer patients.
9) Death:
Death is a critical endpoint in cancer management. Understanding and mitigating the risks associated with cancer treatments is vital to prolonging life and improving the quality of life for patients. Pharmacists play a key role in identifying potential medication errors and adverse effects that could contribute to mortality.
10) Pharmacotherapy:
Pharmacotherapy refers to the use of medications to treat disease. In oncology, it includes a variety of drug therapies tailored to individual patient needs, necessitating pharmacists’ expertise in managing complex medication regimens to ensure safe and effective treatment outcomes for cancer patients.
11) Developing:
Developing in the context of healthcare usually refers to advancing knowledge, skills, or therapeutic strategies. For oncology pharmacists, developing new practices and guidelines in pharmacotherapy can help optimize patient safety and drug efficacy, particularly as new cancer treatments and technologies emerge in clinical practice.
12) Science (Scientific):
Scientific approaches in healthcare emphasize evidence-based practices, critical for effective treatment in oncology. Research and literature serve as foundational resources for pharmacists to understand drug therapies, patient safety protocols, and ongoing advancements in medical knowledge that guide their practice in cancer care.
13) Pose:
Pose often refers to presenting risks or challenges in the context of patient safety. In oncology, the pharmacotherapy process may pose significant risks if not carefully managed. Pharmacists need to identify and mitigate any potential risks to ensure safe medication use and enhance treatment efficacy.
14) Redistribution:
Redistribution in healthcare may refer to reallocating resources or responsibilities among healthcare professionals. Effective redistribution of tasks related to medication management can enhance patient safety and ensure that pharmacists can focus on optimizing pharmacotherapy for oncology patients, particularly in a collaborative, multidisciplinary environment.
15) Performance:
Performance is crucial in evaluating the effectiveness of healthcare interventions, particularly in oncology. The performance of pharmacists in monitoring drug therapies and managing patient care directly impacts patient safety, treatment outcomes, and overall quality of care in cancer management.
16) Discussion:
Discussion refers to the exchange of ideas or findings among healthcare professionals. In the context of this literature, discussions about the role of pharmacists in oncology are essential for recognizing best practices, challenges, and innovations that improve patient safety and treatment outcomes in cancer care.
17) Knowledge:
Knowledge encompasses the information and understanding that healthcare professionals possess concerning patient care and pharmacotherapy. For pharmacists in oncology, extensive knowledge of cancer treatments and pharmacological principles is vital to ensure patient safety and provide the highest standard of care in medication management.
18) Toxicity:
Toxicity refers to the adverse effects of drugs, especially chemotherapeutic agents used in cancer treatment. Understanding the potential toxicities associated with these drugs is critical for pharmacists to provide effective patient education and monitoring, allowing timely interventions to prevent serious complications and enhance patient outcomes.
19) Medicine:
Medicine in the context of oncology encompasses all therapeutic interventions, including pharmacological and non-pharmacological treatments for cancer. The role of pharmacists is to ensure that cancer treatment regimens are safe, effective, and tailored to individual patient needs in collaboration with the multidisciplinary healthcare team.
20) Training:
Training for pharmacists in oncology is essential to equip them with the necessary skills and knowledge to manage complex medication therapies specific to cancer treatment. Ongoing professional development and training help ensure that pharmacists can effectively contribute to patient safety and comprehensive cancer care.
21) Field:
Field pertains to a specific area of professional practice or research. In the context of this literature, 'field' may refer to oncology pharmacy, where pharmacists focus on cancer-related medication management and the integration of their expertise into multidisciplinary teams dedicated to patient care.
22) Cina:
China represents a significant context in this literature where studies regarding oncology pharmacy and patient care may take place. Understanding healthcare practices in countries like China can provide insight into global trends in pharmacotherapy and patient safety, enhancing the overall knowledge for oncologic care.
23) Vega:
Vega likely refers to an author within the studies mentioned who has contributed to research in oncology pharmacy or related areas. Their work may underline significant findings regarding patient safety and the vital role of pharmacists in managing cancer treatments effectively.
24) Sah:
Shah refers to a researcher or author who has conducted significant studies in the field of oncology or pharmacotherapy. Their contributions are critical to understanding the impact of pharmacy practice on patient outcomes and safety, particularly in the context of cancer treatment.
25) Post:
Post generally pertains to the time period following an event. In this literature, it could refer to considerations and practices that evolve after the administration of treatment or after the onset of complications, emphasizing the importance of ongoing patient monitoring and intervention from pharmacists.
26) Pur:
Poor often describes inadequate outcomes or conditions faced by patients, such as poor pain control or adverse reactions to medications. Addressing the causes of poor outcomes through systematic interventions, particularly by pharmacists in oncology, can significantly enhance the quality of patient care and treatment results.
Other Science Concepts:
Discover the significance of concepts within the article: ‘The role of the pharmacist in oncological patient safety’. Further sources in the context of Science might help you critically compare this page with similair documents:
Adverse drug reaction, Drug Interaction, Patient education, Patient safety, Treatment selection, Pharmacovigilance, Clinical decision-making, Multidisciplinary team, Drug-related problem, Chemotherapy regimen.